Sphera Funds Management Ltd. Eliem Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $382 Million
- Q3 2025
A detailed history of Sphera Funds Management Ltd. transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 434,837 shares of ELYM stock, worth $1.79 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
434,837
Previous 209,837
107.23%
Holding current value
$1.79 Million
Previous $862,000
107.31%
% of portfolio
0.47%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding ELYM
# of Institutions
67Shares Held
44.3MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.32MShares$5.41 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.3MShares$5.34 Million0.62% of portfolio
-
Kynam Capital Management, LP Princeton, NJ1.03MShares$4.23 Million0.36% of portfolio
-
Tang Capital Management LLC San Diego, CA1MShares$4.11 Million0.19% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...